GlassScriptPhysician profile
Robert Benjamin Burns
NPI 1720179401
$2,158.46
in general payments reported to CMS, 2019-2025
27 companies · $72.89 in 2025
The $72.89 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $298 · 2021: $378 · 2022: $506 · 2023: $329 · 2024: $135 · 2025: $72.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $265.55 | 2020-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $203.21 | 2019-2024 | Farxiga, Airsupra |
| Novo Nordisk INC | $202.98 | 2019-2025 | |
| Glaxosmithkline, LLC. | $190.58 | 2019-2022 | |
| Pfizer INC. | $158.52 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $145.03 | 2019-2022 | |
| Melinta Therapeutics, LLC | $117.05 | 2022 | |
| Alkermes, INC. | $111.22 | 2019 | |
| Corcept Therapeutics | $110.79 | 2021-2023 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $68.78 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $64.29 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.44 | 2023 | Relistor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.17 | 2021-2024 | Jardiance |
| Astellas Pharma US INC | $51.38 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $51.24 | 2024 | Arcalyst |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36.34 | 2025 | Kyphon Express II Kyphopak Tray, Inceptiv |
| Abbott Laboratories | $35.38 | 2022-2023 | Freestyle Libre 2 |
| Alon Medical Technology | $34.57 | 2022 | |
| Dexcom, INC. | $34.43 | 2022-2023 | Dexcom G6 Transmitter |
| Amgen INC. | $31.91 | 2019-2022 | |
| Abbvie INC. | $22.81 | 2021 | |
| Exact Sciences Corporation | $19.76 | 2024 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $18.72 | 2022 | |
| Inari Medical, INC. | $18.60 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Allergan, INC. | $17.63 | 2020 | |
| Amneal Pharmaceuticals LLC | $16.45 | 2020 | |
| Tandem Diabetes Care, INC. | $10.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.